Donald Campbell’s legendary hydroplane, Bluebird K7 has left Cumbria's Ruskin Museum today for The Aircraft Heritage Trust at ...
The pioneering gene therapy developer will be acquired by investment firms Carlyle Group and SK Capital for a fraction of ...
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as ...
There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...
(NASDAQ:BLUE – Get Free Report) had its target price dropped by analysts at Wells Fargo & Company from $40.00 to $5.00 in a ...
Over the late fall and into the winter, the Eastern Bluebird mural has been taking shape on the side of the 4 Girls And A ...
The Mail on MSN1d
Legendary Bluebird K7 hydroplane departs Coniston for engine fittingDonald Campbell's legendary hydroplane, Bluebird K7, left the Ruskin Museum on Monday, February 24 for engine fitting.
Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.
Dealbreaker on MSN1d
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private EquityCarlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.
Bluebird Bio, Inc. (NASDAQ:BLUE), on Friday, entered into a definitive agreement to be acquired by global investment firms ...
The facility, which opened just over one year ago, has been involved in more than 350 calls to Boulder police since January ...
State-owned bank BNI has partnered with Bluebird to help the taxi operator carry out digital transformation in its services ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback